Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-11
DOI
10.3389/fonc.2019.01412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy
- (2018) Tianbao Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins
- (2018) Maomao Zhang et al. Cancer Discovery
- Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
- (2018) Renumathy Dhanasekaran et al. GASTROENTEROLOGY
- Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
- (2018) Giorgia Zadra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target
- (2017) Douglas Buckley et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival
- (2017) Marin E. Nelson et al. Nature Communications
- FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
- (2017) Timothy S. Heuer et al. EBioMedicine
- Comparison of hepatocellular carcinoma in Eastern versus Western populations
- (2016) Su Pin Choo et al. CANCER
- CD147/Basigin: a Warburg oncogene in hepatocellular carcinoma?
- (2016) Diego Francesco Calvisi et al. Chinese Journal of Cancer Research
- Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors
- (2016) Maria Jose Bueno et al. CURRENT DRUG TARGETS
- Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors
- (2016) Thelma S. Angeles et al. Expert Opinion on Drug Discovery
- Lipid desaturation - the next step in targeting lipogenesis in cancer?
- (2016) Barrie Peck et al. FEBS Journal
- Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
- (2016) Mindy I. Davis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered
- (2016) William B. Kinlaw et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- Bothde novosynthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells
- (2016) Dan Cao et al. LIVER INTERNATIONAL
- MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway
- (2016) Gang Zhao et al. ONCOLOGY REPORTS
- Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
- (2016) Junjie Hu et al. Scientific Reports
- Progress in the development of fatty acid synthase inhibitors as anticancer targets
- (2015) Genevieve E. Mullen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular Pathways: Fatty Acid Synthase
- (2015) S. F. Jones et al. CLINICAL CANCER RESEARCH
- ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment
- (2015) Amrita Khwairakpam et al. CURRENT DRUG TARGETS
- CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways
- (2015) Jibin Li et al. JOURNAL OF HEPATOLOGY
- Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy
- (2015) Colin Rae et al. RADIATION RESEARCH
- Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
- (2015) Richard Ventura et al. EBioMedicine
- The Changing Landscape of Hepatocellular Carcinoma
- (2014) Erik S. Knudsen et al. AMERICAN JOURNAL OF PATHOLOGY
- In Situ Proteome Profiling of C75, a Covalent Bioactive Compound with Potential Anticancer Activities
- (2014) Xiamin Cheng et al. ORGANIC LETTERS
- A Central Role for mTOR in Lipid Homeostasis
- (2013) Dudley W. Lamming et al. Cell Metabolism
- Cellular Fatty Acid Metabolism and Cancer
- (2013) Erin Currie et al. Cell Metabolism
- Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study
- (2013) Jordi Bruix et al. EUROPEAN JOURNAL OF CANCER
- Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids
- (2013) Nousheen Zaidi et al. PROGRESS IN LIPID RESEARCH
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
- (2012) Joana Relat et al. BMC CANCER
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
- (2010) A. Vazquez-Martin et al. CELL PROLIFERATION
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- Trophoblastic Neoplasms Express Fatty Acid Synthase, Which May Be a Therapeutic Target via Its Inhibitor C93
- (2009) Stefanie M. Ueda et al. AMERICAN JOURNAL OF PATHOLOGY
- Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
- (2009) Toshiro Migita et al. JNCI-Journal of the National Cancer Institute
- Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-ketoacyl reductase reaction
- (2008) María Jesús Vázquez et al. FEBS Journal
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma
- (2008) Taro Yamashita et al. JOURNAL OF HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now